Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy , University of North Carolina , Chapel Hill , North Carolina 27599 , United States.
ACS Nano. 2018 Dec 26;12(12):11740-11755. doi: 10.1021/acsnano.8b05893. Epub 2018 Dec 6.
Nanoscience has long been lauded as a method through which tumor-associated barriers could be overcome. As successful as cancer immunotherapy has been, limitations associated with the tumor microenvironment or side effects of systemic treatment have become more apparent. In this Review, we seek to lay out the therapeutic challenges associated with the tumor microenvironment and the ways in which nanoscience is being applied to remodel the tumor microenvironment and increase the susceptibility of many cancer types to immunotherapy. We detail the nanomedicines on the cutting edge of cancer immunotherapy and how their interactions with the tumor microenvironment make them more effective than systemically administered immunotherapies.
纳米科学长期以来一直被誉为克服肿瘤相关障碍的一种方法。尽管癌症免疫疗法取得了成功,但与肿瘤微环境相关的限制或全身性治疗的副作用变得更加明显。在这篇综述中,我们试图阐述与肿瘤微环境相关的治疗挑战,以及纳米科学如何应用于重塑肿瘤微环境,提高许多癌症类型对免疫疗法的敏感性。我们详细介绍了处于癌症免疫疗法前沿的纳米药物,以及它们与肿瘤微环境的相互作用如何使它们比系统给予的免疫疗法更有效。